ONtrack Biomedical AG is a Swiss spin-off of the University Zurich and University Hospital Zurich which develops in-vitro diagnostic tests for the early and non-invasive detection and monitoring of cancer. Our first product is a urine test for the early detection and monitoring of prostate cancer.
Some insights
Our Founders are dedicated scientists and entrepreneurs with extensive expertise in monoclonal antibody development and with comprehensive clinical and research experience in prostate cancer and oncology.
